{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:24:56Z","timestamp":1763706296863,"version":"3.44.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10430022010020"],"award-info":[{"award-number":["10430022010020"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2022,2,10]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Research on the disease severity of COVID-19 in patients with rheumatic immune-mediated inflammatory diseases (IMIDs) has been inconclusive, and long-term prospective data on the development of SARS-CoV-2 antibodies in these patients are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Adult patients with rheumatic IMIDs from the Amsterdam Rheumatology and Immunology Center, Amsterdam were invited to participate. All patients were asked to recruit their own sex-matched and age-matched control subject. Clinical data were collected via online questionnaires (at baseline, and after 1\u20134 and 5\u20139 months of follow-up). Serum samples were collected twice and analysed for the presence of SARS-CoV-2-specific antibodies. Subsequently, IgG titres were quantified in samples with a positive test result.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>In total, 3080 consecutive patients and 1102 controls with comparable age and sex distribution were included for analyses. Patients were more frequently hospitalised compared with controls when infected with SARS-CoV-2; 7% vs 0.7% (adjusted OR: 7.33, 95% CI: 0.96 to 55.77). Only treatment with B-cell targeting therapy was independently associated with an increased risk of COVID-19-related hospitalisation (adjusted OR: 14.62, 95% CI: 2.31 to 92.39). IgG antibody titres were higher in hospitalised compared with non-hospitalised patients, and slowly declined with time in similar patterns for patients in all treatment subgroups and controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interpretation<\/jats:title>\n                  <jats:p>We observed that patients with rheumatic IMIDs, especially those treated with B-cell targeting therapy, were more likely to be hospitalised when infected with SARS-CoV-2. Treatment with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) and biological DMARDs other than B-cell targeting agents is unlikely to have negative effects on the development of long-lasting humoral immunity against SARS-CoV-2.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2021-002035","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:56:39Z","timestamp":1649159799000},"page":"e002035","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-7786","authenticated-orcid":false,"given":"Laura","family":"Boekel","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Hooijberg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik H","family":"Vogelzang","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya\u00eblle R","family":"Besten","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Leeuw","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaf","family":"Atiqi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6438-8663","authenticated-orcid":false,"given":"Ronald F","family":"van Vollenhoven","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla A","family":"Wijbrandts","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn","family":"Gerritsen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-7838","authenticated-orcid":false,"given":"C","family":"Krieckaert","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas","family":"Dijkshoorn","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siham","family":"Bakhlakh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette J","family":"Crooijmans","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Voskuyl","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene E","family":"van der Horst-Bruinsma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-3953","authenticated-orcid":false,"given":"Willem","family":"Lems","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"},{"name":"Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taco W","family":"Kuijpers","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Marieke","family":"van Ham","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luuk","family":"Wieske","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurophysiology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Eftimov","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurophysiology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Y","family":"Kummer","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"},{"name":"Department of Neurology and Neurophysiology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PJ Koos","family":"van Dam","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurophysiology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen W","family":"Stalman","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurophysiology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Steenhuis","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Keijzer","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olvi","family":"Cristianawati","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Keijser","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floris C","family":"Loeff","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander W","family":"Tas","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-1934","authenticated-orcid":false,"given":"Michael T","family":"Nurmohamed","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"},{"name":"Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6969-283X","authenticated-orcid":false,"given":"Maarten","family":"Boers","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"},{"name":"Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands"},{"name":"Department of Epidemiology & Data Science, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Rispens","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertjan","family":"Wolbink","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands"},{"name":"Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"2025090312205522000_8.1.e002035.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217615"},{"key":"2025090312205522000_8.1.e002035.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes305"},{"key":"2025090312205522000_8.1.e002035.3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091844","article-title":"Autoimmune diseases and COVID-19 as risk factors for poor outcomes: data on 13,940 hospitalized patients from the Spanish nationwide SEMI-COVID-19 registry","volume":"10","author":"Ayala Guti\u00e9rrez","year":"2021","journal-title":"J Clin Med"},{"key":"2025090312205522000_8.1.e002035.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102632","article-title":"Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark","volume":"120","author":"Kjeldsen","year":"2021","journal-title":"J Autoimmun"},{"key":"2025090312205522000_8.1.e002035.5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1054\/JHSB.2001.0703","article-title":"Retrospective clinical studies in surgery: potentials and pitfalls","volume":"27","author":"Sauerland","year":"2002","journal-title":"J Hand Surg Br"},{"key":"2025090312205522000_8.1.e002035.6","unstructured":"Eular recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the July 2021 update. Available: https:\/\/www.eular.org\/myUploadData\/files\/eular_recommendations_for_the_management_of_rheumatic_and_musculoskeletal_diseases_in_the_context_of_sars_cov_2_(07_21).pdf"},{"key":"2025090312205522000_8.1.e002035.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103014","article-title":"Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: a case-control study","volume":"52","author":"Conte","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"2025090312205522000_8.1.e002035.8","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2021.1364","article-title":"SARS-CoV-2 antibodies in adult patients with multiple sclerosis in the Amsterdam MS cohort","volume":"78","author":"van Kempen","year":"2021","journal-title":"JAMA Neurol"},{"key":"2025090312205522000_8.1.e002035.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324388"},{"key":"2025090312205522000_8.1.e002035.10","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1016\/S2665-9913(21)00222-8","article-title":"Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies","volume":"3","author":"Boekel","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2025090312205522000_8.1.e002035.11","doi-asserted-by":"crossref","unstructured":"Vogelzang EH , Loeff FC , Derksen NI . Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and non-hospitalized patients with COVID-19. medRxiv 2020.doi:10.1101\/2020.06.17.20133793","DOI":"10.1101\/2020.06.17.20133793"},{"key":"2025090312205522000_8.1.e002035.12","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1285","article-title":"Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors","volume":"10","author":"Steenhuis","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"2025090312205522000_8.1.e002035.13","first-page":"1","article-title":"Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis","author":"Biswas","year":"2020","journal-title":"Intervirology"},{"key":"2025090312205522000_8.1.e002035.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.036434"},{"key":"2025090312205522000_8.1.e002035.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.30580"},{"key":"2025090312205522000_8.1.e002035.16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel366"},{"key":"2025090312205522000_8.1.e002035.17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219498"},{"key":"2025090312205522000_8.1.e002035.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.03.012"},{"key":"2025090312205522000_8.1.e002035.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180153"},{"key":"2025090312205522000_8.1.e002035.20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151244"},{"key":"2025090312205522000_8.1.e002035.21","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s10067-021-05675-x","article-title":"The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia","volume":"40","author":"Espinosa","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025090312205522000_8.1.e002035.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.05.003"},{"key":"2025090312205522000_8.1.e002035.23","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s10067-021-05779-4","article-title":"Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs","volume":"40","author":"Yousefghahari","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025090312205522000_8.1.e002035.24","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2665-9913(20)30286-1","article-title":"Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population","volume":"2","author":"Hooijberg","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2025090312205522000_8.1.e002035.25","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"2025090312205522000_8.1.e002035.26","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14627","article-title":"The risk for severe COVID 19 in patients with autoimmune and\/or inflammatory diseases: first wave lessons","volume":"34","author":"Druyan","year":"2021","journal-title":"Dermatol Ther"},{"key":"2025090312205522000_8.1.e002035.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219279"},{"key":"2025090312205522000_8.1.e002035.28","first-page":"527","article-title":"Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients","volume":"80","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025090312205522000_8.1.e002035.29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26028"},{"key":"2025090312205522000_8.1.e002035.30","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"2025090312205522000_8.1.e002035.31","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc5343"},{"key":"2025090312205522000_8.1.e002035.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4776"},{"key":"2025090312205522000_8.1.e002035.33","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet Microbe"},{"key":"2025090312205522000_8.1.e002035.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01288.x"},{"key":"2025090312205522000_8.1.e002035.35","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27274","article-title":"Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19","volume":"94","author":"Yan","year":"2022","journal-title":"J Med Virol"},{"key":"2025090312205522000_8.1.e002035.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22958-8"},{"key":"2025090312205522000_8.1.e002035.37","doi-asserted-by":"crossref","unstructured":"Oria MP , Kumanyika S , National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board; Committee on the Development of Guiding Principles for the Inclusion of Chronic Disease Endpoints in Future Dietary Reference Intakes, editors . Guiding principles for developing dietary reference intakes based on chronic disease. Washington (DC): National Academies Press (US), 2017.","DOI":"10.17226\/24828"},{"key":"2025090312205522000_8.1.e002035.38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13075-021-02574-z","article-title":"Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic","volume":"23","author":"Boekel","year":"2021","journal-title":"Arthritis Res Ther"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2021-002035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:21:08Z","timestamp":1756927268000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2021-002035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,5]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/rmdopen-2021-002035"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2021-002035","relation":{},"ISSN":["2056-5933"],"issn-type":[{"type":"electronic","value":"2056-5933"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}